Squarepoint’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,900
Closed -$383K 4915
2025
Q4
$383K Buy
+7,900
New +$392K ﹤0.01% 3426
2025
Q1
Sell
-42,300
Closed -$2.04M 5347
2024
Q4
$2.04M Buy
+42,300
New +$2.15M ﹤0.01% 2395
2024
Q1
Sell
-135,000
Closed -$6.71M 4573
2023
Q4
$6.71M Buy
+135,000
New +$6.6M 0.01% 1199

Other funds holding SNY

Squarepoint's SNY Position: Q2 2026 in Review

Squarepoint increased its Sanofi (SNY) stake by 7% in Q2 2026, buying an estimated $357K and bringing the position to 121,857 shares worth $3.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1814.

Squarepoint first reported a position in SNY in Q4 2016 and has held it in 6 quarters since. The position peaked at $3.87M in Q1 2026. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Squarepoint held 121,857 shares of Sanofi worth $3.77M as of Q2 2026.
  • Squarepoint bought 8,000 Sanofi shares in Q2 2026, an estimated $357K.
  • Sanofi made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #1814 holding.
  • Squarepoint first reported a position in Sanofi in Q4 2016 and has held it in 6 quarters since.
  • Squarepoint's Sanofi position peaked at $3.87M in Q1 2026.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.